10 Best Major Stocks to Buy According to Analysts

8. CME Group Inc. (NASDAQ:CME)

Potential Upside: 32.5%

On July 6, Analyst Alex Kramm from UBS reiterated a Hold rating on CME Group Inc. (NASDAQ:CME) while cutting his price target on the stock. The analyst lowered his price target on the shares from $310 to $260. The firm’s revised price target still offers a further 10% upside from here on.

The analyst sticks to his Hold rating due to a mix of positive and negative factors affecting the company. He lowered his short-term earnings forecast after June trading data came in weaker than expected. The data showed slightly weaker pricing and lower futures volumes, particularly in interest rate and energy contracts. According to the analyst, these trends could weigh on CME Group’s transaction revenue, even as trading activity remains above last year’s levels.

At the same time, Analyst Alex Kramm said that businesses such as IRS clearing and BrokerTec continue to perform well. However, he remains cautious about whether trading volumes can continue growing, citing increasing competition from perpetual futures and potential regulatory risks.

On the same day, Barclays also maintained its Hold rating on CME Group Inc. (NASDAQ:CME) with a price target of $316. The difference in price targets indicates that analysts are still divided on the company’s outlook.

CME Group Inc. (NASDAQ:CME) allows institutional participants to manage risk and trade futures, options, and indices across all major asset classes. The exchange offers highly regulated, cash-settled derivatives such as Bitcoin and Ethereum futures, as well as crypto-index products.